| Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A … JS Vaidya, F Wenz, M Bulsara, JS Tobias, DJ Joseph, M Keshtgar, ... The Lancet 383 (9917), 603-613, 2014 | 949 | 2014 |
| Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial JS Vaidya, DJ Joseph, JS Tobias, M Bulsara, F Wenz, C Saunders, ... The Lancet 376 (9735), 91-102, 2010 | 911 | 2010 |
| Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial J Cuzick, I Sestak, JF Forbes, M Dowsett, J Knox, S Cawthorn, ... The Lancet 383 (9922), 1041-1048, 2014 | 641 | 2014 |
| Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study ER Copson, TC Maishman, WJ Tapper, RI Cutress, S Greville-Heygate, ... The lancet oncology 19 (2), 169-180, 2018 | 427 | 2018 |
| Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer JS Vaidya, M Baum, JS Tobias, DP D’Souza, SV Naidu, S Morgan, ... Annals of Oncology 12 (8), 1075-1080, 2001 | 305 | 2001 |
| 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial HM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ... The Lancet 393 (10191), 2599-2612, 2019 | 294 | 2019 |
| Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding B Belletti, JS Vaidya, S D'Andrea, F Entschladen, M Roncadin, F Lovat, ... Clinical Cancer Research 14 (5), 1325-1332, 2008 | 292 | 2008 |
| Multicentricity of breast cancer: whole-organ analysis and clinical implications JS Vaidya, JJ Vyas, RF Chinoy, N Merchant, OP Sharma, I Mittra British journal of cancer 74 (5), 820-824, 1996 | 292 | 1996 |
| A mathematical model of breast cancer development, local treatment and recurrence H Enderling, MAJ Chaplain, ARA Anderson, JS Vaidya Journal of theoretical biology 246 (2), 245-259, 2007 | 257 | 2007 |
| COVID-19: global radiation oncology’s targeted response for pandemic preparedness R Simcock, TV Thomas, CE Mercy, AR Filippi, MA Katz, IJ Pereira, ... Clinical and Translational Radiation Oncology, 2020 | 246 | 2020 |
| Intraoperative radiotherapy for breast cancer JS Vaidya, JS Tobias, M Baum, M Keshtgar, D Joseph, F Wenz, ... The lancet oncology 5 (3), 165-173, 2004 | 239 | 2004 |
| Omission of nitrous oxide during anesthesia reduces the incidence of postoperative nausea and vomiting: a meta-analysis JV Divatia, JS Vaidya, RA Badwe, RW Hawaldar The Journal of the American Society of Anesthesiologists 85 (5), 1055-1062, 1996 | 239 | 1996 |
| Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised … JS Vaidya, M Bulsara, M Baum, F Wenz, S Massarut, S Pigorsch, ... bmj 370, 2020 | 231 | 2020 |
| Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population JS Vaidya Journal of the National Cancer Institute 100 (08), 598-599, 2008 | 206* | 2008 |
| Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II … JF Forbes, I Sestak, A Howell, B Bonanni, N Bundred, C Levy, ... The Lancet 387 (10021), 866-873, 2016 | 203 | 2016 |
| The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer JS Vaidya, M Baum, JS Tobias, S Morgan, D D'Souza European Journal of Surgical Oncology (EJSO) 28 (4), 447-454, 2002 | 193 | 2002 |
| Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial J Cuzick, I Sestak, JF Forbes, M Dowsett, S Cawthorn, RE Mansel, S Loibl, ... The lancet 395 (10218), 117-122, 2020 | 188 | 2020 |
| Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery JS Vaidya, M Baum, JS Tobias, F Wenz, S Massarut, M Keshtgar, B Hilaris, ... International Journal of Radiation Oncology* Biology* Physics 81 (4), 1091-1097, 2011 | 181 | 2011 |
| Ischemic heart disease after breast cancer radiotherapy MP Little, LB Zablotska, SE Lipshultz N. Engl. J. Med 368 (26), 2523-4, 2013 | 174* | 2013 |
| Prediction of nipple and areola involvement in breast cancer JJ Vyas, RF Chinoy, JS Vaidya European Journal of Surgical Oncology (EJSO) 24 (1), 15-16, 1998 | 174 | 1998 |
Max BulsaraInstitute for Health Research, University of Notre Dame Australia在 nd.edu.au 的电子邮件经过验证
